Diseases & Disorders
(G11)
IRS Verified
DX Registered
990 on File
MELANOMA RESEARCH ALLIANCE FOUNDATION
Financial strength (30%)
69/100
Reliability (20%)
50/100
Effectiveness (25%)
81/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$16.5M
Total Revenue
$17.4M
Total Expenses
$11.8M
Net Assets
16
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
92.1%
Fundraising Efficiency
665.2%
Operating Reserve
8.10x
Liability-to-Asset
53.3%
Revenue Diversification
96.7%
Executive Compensation
$1.1M
Compared with Peers
FY 2024
Compared with 166 similar organizations
(United States, Diseases & Disorders, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
92.1% | 86.7% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
3.6% | 10.3% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
4.3% | 0.5% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
665.2% | 280.6% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
8.1 mo | 7.8 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
53.3% | 28.9% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
96.7% | 90.7% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
77.4% | 7.7% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
69.1% | 7.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-5.8% | 1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $16.5M | $17.4M | $11.8M | 92.1% | 16 |
| 2023 | $9.3M | $10.3M | $13.0M | 86.2% | 12 |
| 2022 | $11.6M | $15.7M | $13.9M | 90.9% | 17 |
| 2021 | $7.5M | $11.3M | N/A | — | 14 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.